BE531461A - - Google Patents

Info

Publication number
BE531461A
BE531461A BE531461DA BE531461A BE 531461 A BE531461 A BE 531461A BE 531461D A BE531461D A BE 531461DA BE 531461 A BE531461 A BE 531461A
Authority
BE
Belgium
Prior art keywords
sep
coconut oil
palatable
absorb
easy
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE531461A publication Critical patent/BE531461A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE531461D BE531461A (cs)

Publications (1)

Publication Number Publication Date
BE531461A true BE531461A (cs)

Family

ID=163791

Family Applications (1)

Application Number Title Priority Date Filing Date
BE531461D BE531461A (cs)

Country Status (1)

Country Link
BE (1) BE531461A (cs)

Similar Documents

Publication Publication Date Title
US7115565B2 (en) Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
CA2567075C (en) Pharmaceutical suspension composition
US6001870A (en) Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
US6287592B1 (en) Aqueous drink composition comprising ibuprofen
US5505961A (en) Gelatin capsules containing a highly concentrated acetaminophen solution
US6426363B1 (en) Calcium mupirocin sprayable formulation
JPH09328427A (ja) 新規なフェノフィブラート含有製薬用組成物及びそれらの用途
NZ539046A (en) Chemotherapeutic self-emulsifying microemulsion compositions of paclitaxel with improved oral bioavailability
JP2000500504A (ja) Ｖｘ ４７８のようなｈｉｖプロテアーゼ阻害剤およびビタミンｅ―ｔｐｇｓのような水溶性ビタミンｅを含む組成物
BE531461A (cs)
WO1999051219A1 (en) Pleuromutilin derivatives for treating nasopharynx infection
JPH06505749A (ja) １，４−置換ピペリジンの誘導体に基づく新規液体組成物
EP1286660B1 (fr) Composition pharmaceutique sous forme liquide destinee a l'administration par voie orale d'un principe actif, ayant un gout desagreable, notamment un gout amer
US20060217320A1 (en) Soft gel formulations for saquinavir
JPH0477426A (ja) 血管平滑筋弛緩剤
JP2002502878A (ja) ベンゾキサジノンｈｉｖ逆転写酵素阻害剤の経口液体調合物
BE534204A (cs)
JPS62267223A (ja) 抗高血圧剤
HK1172252A (en) Pharmaceutical suspension composition
AU2002249926A1 (en) Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
HK1021941B (en) Drinkable ibuprofen composition
BE546495A (cs)
HK1034468A (en) Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors